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Assessment of hearing ability with pure-tone audiometry and otoacoustic
emission methods in patients undergoing spinal anesthesia
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Aim: To investigate the frequency of hearing loss after spinal anesthesia in patients undergoing spinal anesthesia using pure-tone
audiometry and otoacoustic emission methods.
Materials and methods: A total of 80 patients (40 females, 40 males, aged 18–65 years) were included in the study. For spinal anesthesia,
a 27-gauge Quincke spinal needle was entered at the first attempt into the subarachnoidal space through the L4–L5 interval with the
patient in the lateral decubitus position. The first day before spinal anesthesia, pure-tone audiometry, transient evoked otoacoustic
emission, distortion product otoacoustic emission, and tympanometry were performed on all patients, and the same procedures were
repeated on the postoperative second day.
Results: No problem was encountered related to surgery and anesthesia in any of the patients. Comparative pre- and postoperative
results of pure-tone audiometry performed on the right and left ears were not significantly different in any of the patients (P > 0.05).
Additionally, the outcomes of pre- and postoperatively performed transient evoked otoacoustic emission and of distortion product
otoacoustic emission of both ears were not significantly different (P > 0.05).
Conclusion: According to our study, spinal anesthesia performed with a 27-gauge Quincke needle does not cause transient or permanent
hearing loss.
Key words: Hearing, spinal anesthesia, spinal needle, otoacoustic emission

1. Introduction
Single-dose spinal anesthesia (SA) is one of the most
frequently used, easily applicable, and effective central
blockage methods with perfect tolerability. SA is
performed in lower extremity, lower abdominal quadrant,
and perineal regional surgeries (1–5). However, SA may
have some complications, such as headache, hypotension,
tinnitus, vertigo, paresthesia, nausea, vomiting, and
cranial nerve lesions (3–6). Following SA, unilateral or
bilateral, transient or persistent hearing loss can occur.
Most hearing loss is detected at very low frequencies and
recovers spontaneously (5,7,8). The side effects of the
drugs used, leakage of cerebrospinal fluid (CSF) from the
dura mater after SA, or an ischemic episode may cause
hearing loss. It has been indicated that leakage from the
dura mater could decrease intracochlear pressure, leading
to hearing loss (2,12). Furthermore, various studies have
demonstrated that because of effects on the amount of CSF
coming from ruptured dura mater, the size and the shape
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of the needle play important roles in hearing loss (5,9,10).
Patient age has also been cited as an influential factor in
hearing loss following SA (9–11).
After the description by Kemp in 1978, the otoacoustic
emission (OAE) method has become a widely used
clinical and diagnostic hearing test. OAE is a low-pitch
sound created by outer cochlear hairy cells as a response
to a spontaneous or acoustic stimulus. It is an objective,
noninvasive, frequency-specific, and easily applicable
method evaluating intracochlear activity (12,13).
In this study, we aimed to assess the presence of
hearing loss (if any) in patients undergoing SA using pure
tone audiometry, transient evoked otoacoustic emission
(TEOAE), and distortion product otoacoustic emission
(DPOAE) methods.
2. Materials and methods
Following approval (2009-12/14) of the Ethics Committee
of Clinical Research of the Cumhuriyet University Faculty
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of Medicine, written and undersigned informed consent
forms were obtained from all study participants. Eighty
patients (40 female, 40 male) aged 18–65 years and
scheduled for American Society of Anesthesiologists I–II
orthopedic surgery (lower extremity surgery), urologic
surgery, and general surgery (lower abdominal quadrant
surgery) were included in the study. Patients with normal
otoscopic examination findings, hearing thresholds
lower than 25 dB in pure-tone audiometry, and type
A tympanograms were enrolled. Previous ear surgery,
presence of structural and mechanical occlusive problems
leading to hearing loss, tympanic membrane perforation,
frequent episodes of otitis media, tinnitus, inability to
cooperate, hypertension, diabetes mellitus, and known
allergic reaction to amide-type local anesthetics were the
exclusion criteria of the study.
All patients received 2 mg of intravenous (IV)
midazolam 30 min prior to surgery. Concomitant with
the premedication, 10 mL/kg hydroxyethyl starch was
infused for 20 min, and then infusion was maintained
with isotonic solution (0.09%) at an hourly rate of 10 mL/
kg. Bradycardia (≤50 beats/min) was treated with 0.5
mg atropine, and hypotension (≤30% decrease from the
baseline value) was treated with 5–10 mg IV ephedrine.
After access into the subarachnoidal space with a 27-gauge
Quincke needle through the L4–L5 interval at the first
attempt while the patient was in the lateral decubitus
position, 15 mg 0.5% heavy bupivacaine was injected
into the subarachnoidal space. Sensorial block level was
evaluated with a pin prick test, and when sensorial block
reached the T10 level, surgery was started.
The first day before spinal anesthesia, all patients
underwent pure-tone audiometry (Interacoustics AC
40, Clinical Audiometer, Denmark), tympanometry
(Interacoustics AZ 26, Impedance Audiometer, Denmark),
and TEOAE and DPOAE (Capella Cochlear Emission
Analyzer, Madsen, Denmark) tests. The same procedures
were repeated on the postoperative second day. All hearing
tests were performed in a noiseless room. TEOAE wave

forms were retrieved as a response to a series of acoustic
click stimuli for 80 µs, peaking at 80 ± 2 dB. A total of
260 sweeps at a level of >47 dB were created in a setting
where effects of noise were minimalized. Four successive
clicks were applied, and the fourth click was delivered at a
3-fold higher amplitude than the sum of the first 3 clicks,
at inverse polarity and in nonlinear mode. The presence of
TEOAE was accepted when the responses were elicited at
≥3 dB above the baseline noise level. All TEOAE responses
were analyzed between frequencies of 1 and 5 kHz. DPOAE
was defined as the response evoked with pure-tone stimuli
of 2 different frequencies (2f1–f2) applied at an f2/f1 ratio of
1.2. The intensities of f1 and f2 were determined as 65 and
55 dB, respectively. The presence of DPOAE was accepted
when a 2f1–f2 response was elicited at ≥3 dB above the
baseline noise level. DPOAE responses were elicited and
analyzed within a frequency interval of 750–8000 Hz (750,
1000, 1500, 2000, 3000, 4000, 6000, and 8000 Hz). In puretone audiometry, a frequency interval of 250–6000 Hz
(250, 500, 1000, 2000, 4000 and 6000 Hz) was measured,
and an increase of ≥10 dB above the hearing threshold
detected for air and/or bone conduction pathways was
evaluated as hearing loss.
3. Results
No intraoperative surgical or anesthetic problems were
encountered. In none of the patients were urinary
retention, headache, vertigo, or nerve damage observed.
Preoperative and postoperative blood pressures were
similar in all groups (P > 0.05). Intraoperative bleeding
was negligible in all patients.
No significant difference was found between the preand postoperative pure-tone audiometry results of the
right and left ears at frequencies of 250, 500, 1000, 2000,
4000, and 6000 Hz (P > 0.05) (Table).
There were no differences between the pre- and
postoperative DPOAE results of both ears at frequencies at
750, 1000, 1500, 2000, 3000, 4000, 6000, and 8000 Hz (P >
0.05) (Figures 1a and 1b).

Table. The evaluation of hearing level in spinal anesthesia.
Frequency (Hz)

Preoperative
R

Postoperative
L

R

L

P-value

250

14.37 ± 4.16

14.81 ± 4.99

14.75 ± 4.69

15.06 ± 5.36

NS

500

11.56 ± 4.74

11.31 ± 4.19

12.81 ± 11.90

12.00 ± 4.67

NS

1000

10.93 ± 4.04

9.75 ± 4.35

11.08 ± 4.44

9.93 ± 4.53

NS

2000

8.37 ± 4.11

9.50 ± 5.43

8.68 ± 4.68

9.75 ± 5.33

NS

4000

11.68 ± 5.89

12.50 ± 5.95

11.18 ± 5.52

11.68 ± 5.89

NS

6000

12.75 ± 6.00

12.87 ± 6.45

12.43 ± 5.45

13.75 ± 5.70

NS

R: right ear. L: left ear. NS: not significant.
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Figure 1. Diagram demonstrating pre- and postoperative mean DPOAE amplitudes for a) the right ears and b) the left ears.
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Figure 2. Diagram demonstrating pre- and postoperative mean TEOAE amplitudes for a) the right ears and b) the left ears.

The mean preoperative and postoperative TEOAE
amplitudes of both ears at frequencies of 0.75, 1.25, 1.75,
2.5, 3.5, and 4.5 kHz were not different (P > 0.05) (Figures
2a and 2b).
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4. Discussion
Although hearing loss after SA is not a prevalent
complication, many case reports have nonetheless been
cited in the literature (5–11). Generally, these hearing
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losses are of sudden onset, developing at most 2 days after
SA and resolving spontaneously without any treatment
(5–11). However, some cases persist up to 2 years after SA,
and permanent hearing loss has been observed (5,7,8).
Although the mechanism of hearing loss is not
known in detail, the development of hearing loss as an
outcome of endolymphatic hydrops has been suggested.
The cochlea has a hard bony structure that allows the
free movement of the intracochlear fluid only through
oval and round windows. The inner ear fluid is made up
of the endolymph and the perilymph, which are found
in different incompressible compartments separated by
membranes. Since total bone volume does not change,
a decrease in fluid volume in one compartment might
lead to a relative increase in the other fluid component
or a positional change of the windows. The perilymph
communicates with the subarachnoidal space through the
cochlear aqueduct. Therefore, a decrease in CSF volume
conceivably might result in a decrease in the volume of
perilymph fluid and thus in transient endolymphatic
hydrops, and this fluid imbalance might be normalized by
replacing perilymph fluid loss (5,7,14–18). This hypothesis
prompted studies to be carried out on the evaluation of
hearing loss after SA. Walsted et al. (16) investigated the
loss in CSF volume in hearing loss. They divided patients
into 4 study groups as follows: the SA group with minimal
CSF loss, the neurosurgery group with moderate CSF loss,
the acoustic neurinoma surgery group with maximal CSF
loss, and the control group. They found that hearing loss,
deterioration in hearing frequencies and loss in hearing
threshold, and CSF volume were at maximal levels in the
acoustic neurinoma surgery group. They also showed that
these deficiencies in hearing ability had spontaneously and
completely returned to their normal levels.
Many investigations have also demonstrated the critical
importance of the size and shape of the spinal needles
used in spinal anesthesia in the development of hearing
loss (2,5–7). Erol et al. (2) conducted investigations using
25-gauge pencil point, ball pen, and Quincke needles and
reported that hearing loss was most frequently observed
in the Quincke needle group, emphasizing the preference
for blunt-tipped needles. In another study where 22- and
27-gauge pencil point needles were compared, the authors
detected a lower incidence of hearing loss with small-sized
needles, and the use of small-sized needles in SA was
emphasized (5). Similarly, Malhotra et al. (7) compared
23- and 26-gauge Quincke needles and recommended the
use of small-sized needles because a lower incidence of
hearing loss was encountered.
Some studies have also demonstrated the potential
impact of patient age on hearing loss occurring after SA
(9–11,19). Ok et al. (10) and Güçlü et al. (9) detected

higher incidences of hearing loss at lower frequencies
after SA more often in the elderly, and they attributed this
phenomenon to an increased sensitivity of the middle ear
to minor alterations in cerebrospinal fluid in the elderly.
Similar outcomes were reported in a study performed
on females receiving cesarean sections under SA (19).
Contrary to these findings, Gültekin et al. (11) asserted
that hearing loss is more frequently seen in individuals
of ≤30 years of age than in older patients and associated
this finding with more abundant CSF leakage due to the
perforation of dura mater. They stated that the incidence
of postdural headache increased in direct proportion to
CSF leakage, and they asserted that a decreased incidence
of this type of headache in the elderly supported the
outcomes of their investigation.
The impact of SA on hearing ability has also been
evaluated by tests other than pure-tone audiometry
(20,21). Schaffartzik et al. (21) applied a test evaluating
tympanic membrane displacement in order to measure
intracochlear pressure, but they found no difference
between pre- and postoperative measurements. Karatas
et al. (20) investigated the OAE responses of outer hair
cells so as to analyze intracochlear activity in 11 patients.
Comparisons of preoperative and postoperative first
day values in TEOAE tests revealed decreases in mean
amplitudes at frequencies of 1000, 2000, and 3000 Hz.
Meanwhile, DPOAE analyses detected decrements in
mean amplitudes at frequencies of 1500, 2000, and 3000
Hz.
Various studies have reported the presence or,
conversely, the absence of hearing loss in patients after SA
(5,7,10,19). In our study, hearing loss did not develop in
any of our patients after SA. Furthermore, no significant
difference was observed between mean air conduction
thresholds or mean TEOAE and DPOAE amplitudes
before and after SA. On the other hand, Malhotra et al.
(7) and Cosar et al. (5) respectively used 26- and 27-gauge
Quincke needles during SA, and none of their study
patients suffered from hearing loss. In our study, we used
27-gauge needles and thus minimized CSF leakage with a
resultant absence of hearing loss. Consequently, we did not
find any difference between mean TEOAE and DPOAE
values estimated before and after SA. Therefore, decreasing
the needle size might decrease the risk of hearing loss or
even reduce it to zero.
In conclusion, in the present study there were no
differences between pre- and postoperative measurement
in pure-tone audiometry, TEOAE, and DPOAE. In light of
our study, the use of smaller-sized Quincke needles during
SA is thought to be effective in preventing the occurrence
of hearing loss. However, further studies are needed to
substantiate our results.
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